Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.6.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BF.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.5.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BN.1.3.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BF.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BN.1.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.2.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
ED.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BN.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
CQ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
CH.1.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.2.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.38.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.19.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.214EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.284EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351.3 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.318EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
R.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ML.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.283EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.96EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.407EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.423EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.281EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used